Consensus ESG Ratings
Member Sign In
ESG News For Fosun Pharmaceutical
These sites contributed news to this page:
​
-
Pfizer and BioNTech Expand Collaboration with U.S. to Provide 500 Million Additional COVID-19 Vaccine Doses at Not-for-Profit Price for Donation to Poorest Countries
Expanded agreement brings the total number of COVID-19 vaccine doses to be supplied to the U.S. government for donation to one billionEffort contributes to companies’ pledge to deliver two billion COVID-19 vaccine doses to low- and middle-income countries by the end of 2022